Healthpeak Properties, Inc.: Form 10-Q for the period ended Mar 31, 2015
Filed with the SEC on May 5, 2015 and accepted by EDGAR at May 5, 2015, 08:42 ET.
Management's discussion and analysis
As filed, 65,945 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Cautionary Language Regarding Forward-Looking Statements
Statements in this Quarterly Report on Form 10-Q that are not historical factual statements are “forward-looking statements.” We intend to have our forward-looking statements covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include this statement for purposes of complying with those provisions. Forward-looking statements include, among other things, statements regarding our and our officers’ intent, belief or expectation as identified by the use of words such as “may,” “will,” “project,” “expect,” “believe,” “intend,” “anticipate,” “seek,” “forecast,” “plan,” “potential,” “estimate,” “could,” “would,” “should” and other comparable and derivative terms or the negatives thereof. Any such forward-looking statements reflect our current expectations and views about future events and are subject to a number of risks and uncertainties that could significantly affect the Company’s future financial condition and results of operations. While forward-looking statements reflect our good faith belief and reasonable assumptions based upon current information, we can give no assurance that our expectations or forecasts will be attained. Further, we cannot guarantee the accuracy of any such forward-looking statement contained in this Quarterly Report, and such forward-looking statements are subject to known and unknown risks and uncertainties that are difficult to predict. As more fully set forth under “Part I, Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014, as updated by Item 1A hereof, risks and uncertainties that may cause our actual results to differ materially from the expectations contained in the forward-looking statements include, among other things:
(a) our ability to fully evaluate HCRMC’s ability to meet its contractual obligations under the HCRMC Lease Amendment and risks related to the impact of the Department of Justice lawsuit against HCRMC, including the possibility of larger than expected litigation costs, adverse results and related developments;
(b) our reliance on a concentration of a small number of tenants and operators for a significant portion of our revenues;
(c) the financial weakness of tenants and operators, including potential bankruptcies, significant litigation exposure and downturns in their businesses, which results in uncertainties regarding our ability to continue to realize the full benefit of such tenants’ and/or operators’ leases;
(d) the ability of our tenants and operators to conduct their respective businesses in a manner sufficient to maintain or increase their revenues and to generate sufficient income to make rent and loan payments to us and our ability to recover investments made, if applicable, in their operations;
(e) competition for tenants and operators, including with respect to new leases and mortgages and the renewal or rollover of existing leases;
(f) availability of suitable properties to acquire at favorable prices and the competition for the acquisition and financing of those properties;
(g) our ability to negotiate the same or better terms with new tenants or operators if existing leases are not renewed or we exercise our right to replace an existing tenant or operator upon default;
(h) the risks associated with our investments in joint ventures and unconsolidated entities, including our lack of sole decision making authority and our reliance on our partners’ financial condition and continued cooperation;
(i) the risk that we may not be able to achieve the benefits of investments within expected time frames or at all, or within expected cost projections;
(j) the potential impact of future litigation matters, including the possibility of larger than expected litigation costs, adverse results and related developments;
(k) the effect on healthcare providers of legislation addressing entitlement programs and related services, including Medicare and Medicaid, which may result in future reductions in reimbursements;
(l) changes in federal, state or local laws and regulations, including those affecting the healthcare industry that affect our costs of compliance or increase the costs, or otherwise affect the operations, of our tenants and operators;
(m) volatility or uncertainty in the capital markets, the availability and cost of capital as impacted by interest rates, changes in our credit ratings, and the value of our common stock, and other conditions that may adversely impact our ability to fund our obligations or consummate transactions, or reduce the earnings from potential transactions;
(n) changes in global, national and local economic conditions, and currency exchange rates;
(o) changes in the credit ratings on United States (“U.S.”) government debt securities or default or delay in payment by the U.S. of its obligations;
(p) our ability to manage our indebtedness level and changes in the terms of such indebtedness; and
(q) the ability to maintain our qualification as a real estate investment trust.
Except as required by law, we undertake no, and hereby disclaim any, obligation to update any forward-looking statements, whether as a result of new information, changed circumstances or otherwise.
The information set forth in this Item 2 is intended to provide readers with an understanding of our financial condition, changes in financial condition and results of operations. We will discuss and provide our analysis in the following order:
- Executive Summary
- 2015 Transaction Overview
- Dividends
- Results of Operations
- Liquidity and Capital Resources
- Contractual Obligations
- Off-Balance Sheet Arrangements
- Inflation
- Non-GAAP Financial Measures Reconciliations
- Critical Accounting Policies
- Recent Accounting Pronouncements
Executive Summary
HCP, an S&P 500 company, invests primarily in real estate serving the healthcare industry in the United States. We are a Maryland corporation organized in 1985 and qualify as a self-administered real estate investment trust (“REIT”). We acquire, develop, lease, manage and dispose of healthcare real estate, and provide financing to healthcare providers. At March 31, 2015, our portfolio of investments, including properties in our unconsolidated joint ventures, consisted of interests in 1,196 facilities.
We invest and manage our real estate portfolio for the long-term to maximize the benefit to our stockholders and support the growth of our dividends. The core elements of our strategy are: (i) to acquire, develop, lease, own and manage a diversified portfolio of quality healthcare properties across multiple business segments and geographic locations (including Europe); (ii) to align ourselves with leading healthcare companies, operators and service providers, which over the long-term should result in higher relative rental rates, net operating cash flows and appreciation of property values; (iii) to concentrate on longer-term escalating triple-net leases with high-quality tenants, while using RIDEA structures for properties that have higher growth potential; (iv) to maintain adequate liquidity with long-term fixed rate debt financing with staggered maturities, which supports the longer-term nature of our investments, while reducing our exposure to interest rate volatility and refinancing risk at any point in the interest rate or credit cycles; and (v) to continue to manage our balance sheet with a targeted financial leverage of 40% relative to our assets.
We believe that our longer-term escalating triple-net leases with financially strong tenants and operators enhance the quality, stability and growth of our rental income. Further, we believe many of our existing properties hold the potential for increased future cash flows due to their high quality and desirable locations within markets where the creation of new supply is limited by the lack of available sites and the difficulty of obtaining the necessary licensing, other approvals and/or financing. Our strategy for maximizing the benefits from these opportunities is to: (i) work with new or existing tenants and operators to address their space and capital needs and (ii) provide high-quality property management services in order to motivate tenants to renew, expand or relocate into our properties.
The delivery of healthcare services requires real estate and, as a result, tenants and operators depend on real estate, in part, to maintain and grow their businesses. We believe that the healthcare real estate market provides investment opportunities due to the: (i) compelling demographics driving the demand for healthcare services; (ii) specialized nature of healthcare real estate investing; and (iii) ongoing consolidation of the fragmented healthcare real estate sector.
While we emphasize healthcare real estate ownership, we may also provide real estate secured financing to, or invest in equity or debt securities of, healthcare operators or other entities engaged in healthcare real estate ownership. We may also acquire all or substantially all of the securities or assets of other REITs, operating companies or similar entities where such investments would be consistent with our investment strategies. We may co-invest alongside institutional or development investors through partnerships or limited liability companies.
We monitor, but do not limit, our investments based on the percentage of our total assets that may be invested in any one property type, investment vehicle or geographic location, the number of properties that may be leased to a single tenant or operator, or loans that may be made to a single borrower. In allocating capital to our multiple segments, we target opportunities with the most attractive risk/reward profile for our portfolio as a whole. We may take additional measures to mitigate risk, including diversifying our investments (by sector, geography, tenant or operator), structuring transactions as master leases, requiring tenant or operator insurance and indemnifications, and obtaining credit enhancements in the form of guarantees, letters of credit or security deposits.
Because our REIT qualification requires us to distribute at least 90% of our REIT taxable income (excluding net capital gains), we regularly access the public equity and debt markets to raise the funds necessary to finance acquisitions and debt investments, develop and redevelop properties, and refinance maturing debt.
We maintain a conservative balance sheet by actively managing our debt to equity levels, using long-term fixed rate debt and staggering our contractual maturities. We also utilize multiple sources of capital including equity, unsecured bonds, revolving line of credit facilities, term loans, and secured debt. We have relationships with institutional joint venture partners which has been a source of capital for our joint ventures.
We evaluate multiple sources of capital when financing our investments. For debt investments, we may utilize our revolving line of credit facility or originate bank term loans. Typically we fund long term real estate investments with common stock and long term unsecured bonds. Additionally, in connection with joint ventures, we typically utilize non-recourse mortgage debt.
2015 Transaction Overview
HCR ManorCare Updates
During the quarter ended March 31, 2015, HCP and HCRMC agreed to market for sale the real estate and operations associated with up to 50 non-strategic assets that are under the Master Lease and Security Agreement (the “Master Lease”) for an estimated total gross sales price between $250 million and $350 million. Six assets are currently under a letter of intent for sale. HCRMC will receive an annual rent reduction under the Master Lease based on 7.75% of the net sales proceeds received by HCP. The asset sales are expected to occur during the second half of 2015 and the first quarter of 2016.
Additionally, HCP and HCRMC agreed to amend the Master Lease (the “HCRMC Lease Amendment”). Commencing April 1, 2015, HCP provided an annual net rent reduction of $68 million, which equates to initial lease year rent of $473 million, compared to $541 million that would have commenced April 1, 2015 prior to the HCRMC Lease Amendment. The contractual rent will increase by 3.0% annually during the initial term. In exchange, HCP will receive the following consideration:
- Fee ownership in nine post-acute facilities valued at $275 million with a median age of four years, currently owned and operated by HCRMC, which transfer is expected to be completed within the next 12 months, subject to customary licensing and regulatory approvals; until the transfer is complete, HCP will retain a lease receivable of equal value, earning income of $19 million annually (included in the amended initial lease year rent of $473 million above);
- A second lease receivable with an initial amount of $250 million, payable by HCRMC upon the earlier of: (i) the end of the initial term of the first renewal pool under the HCRMC Lease Amendment, or (ii) certain capital or liquidity events of HCRMC, including an IPO or sale. The $250 million lease receivable amount will increase each year as follows: 3.0% in April 2016 through 2018, 4.0% in 2019, 5.0% in 2020 and 6.0% in 2021 until the end of the initial lease term; and
- Extension of the initial lease term by five years, to an average of 16 years.
We recorded a non-cash impairment charge of $478 million related to our direct financing lease (“DFL”) investments with HCRMC. The non-cash charge reduced the carrying value of the HCRMC DFL investments from $6.6 billion to $6.1 billion, which represents the present value of the future lease payments under the HCRMC Lease Amendment.
HCRMC’s operating performance for the quarter ended March 31, 2015 reflects year-over-year EBITDAR growth of 3.6%, driven by reimbursement rate increases and continued cost controls. HCRMC’s normalized fixed charge coverage ratio for the trailing twelve months ended March 31, 2015 of 1.08x is consistent with the prior quarter and does not reflect the net $68 million annual rent reduction from the HCRMC Lease Amendment (effective on April 1, 2015) or the potential asset sales discussed above. At March 31, 2015, HCRMC’s cash and cash equivalents increased to $142 million.
See Note 6 to the Consolidated Financial Statements for additional discussion on the HCRMC Lease Amendment and impairment of our HCRMC direct financing lease investment. The United States Department of Justice (“DOJ”) filed a complaint against HCRMC that was released from seal on April 20, 2015 (see Note 8 to the Consolidated Financial Statements).
The Cove Development
In February 2015, we began construction on the first phase, $177 million, of The Cove at Oyster Point, a life science development in South San Francisco, California. The first phase includes two “class A” buildings totaling 253,000 sq. ft. that are expected to be completed in the third quarter of 2016.
HC-One Investment in U.K.
In February 2015, we increased our U.K. HC-One debt investment (“HC-One Facility”) by £108 million to £502 million in conjunction with HC-One’s acquisition of Meridian Healthcare. The HC-One Facility is secured by 303 nursing and residential care homes representing over 13,900 beds in the U.K., primarily located in England and Scotland.
In April 2015, we converted £174 million of our HC-One Facility to fee ownership in a portfolio of 36 care homes under long term triple-net leases that provide aggregate rent in the first year of £13 million. The contractual rent will increase annually by the Retail Price Index (“RPI”) and will be reset to fair market rent at the end of lease years 15 and 25. The triple-net leases have initial terms of 30 years with lessee termination options at the end of lease years 15 and 25.
Other Investment Transactions
In March 2015, we formed a new RIDEA joint venture (“MBK JV”) with MBK Senior Living (“MBK”), a subsidiary of Mitsui & Co. Ltd, that acquired three senior housing facilities for $126 million with HCP and MBK each owning a 50% equity interest. MBK manages these communities on behalf of this joint venture. At closing, we contributed $27 million of cash and MBK contributed the three senior housing facilities, which were encumbered by $78 million of mortgage debt. The MBK JV intends to acquire additional senior housing facilities by focusing on off-market transactions.
During the quarter ended March 31, 2015, we commenced on $65 million of other development projects.
In March 2015, we exercised the purchase option under our $18 million development loan and acquire a newly developed assisted living and memory care facility in Houston, Texas for $36 million. The facility is managed by Brookdale Senior Living Inc. (“Brookdale”) and at closing was 98.9% occupied and placed in a RIDEA structure with Brookdale acquiring a 10% noncontrolling interest.
$849 Million Acquisition of Private Pay Senior Housing Portfolio
In March 2015, HCP and Brookdale entered into a definitive agreement to acquire from Chartwell Retirement Residences a portfolio of 35 private pay senior housing communities, including two leasehold interests, representing 5,025 units (the “Chartwell Portfolio”) for $849 million. The Chartwell Portfolio will be acquired in a RIDEA structure, and Brookdale will acquire a 10% noncontrolling interest. Brookdale has operated these communities since 2011 after its acquisition of Horizon Bay, and will continue to manage the communities post-closing under a long-term management agreement, which is cancellable under certain conditions, subject to a fee if terminated within the next seven years. The closing of this acquisition is expected in the third quarter and remains subject to regulatory approvals and other customary closing conditions.
Additional Investments Through May 5, 2015
In April 2015, we acquired a medical office building (“MOB”) for $161 million. The MOB is located in Philadelphia, Pennsylvania with 705,000 rentable sq. ft. and is currently 85% occupied.
In April 2015, we exercised our purchase option under our $41 million development loan to acquire a newly developed assisted living and memory care facility in Germantown, Tennessee for $72 million. The facility will be managed by Brookdale and placed in a RIDEA structure with Brookdale acquiring a 10% noncontrolling interest. We expect to close this acquisition in the second quarter of 2015, subject to customary closing conditions.
Financing Activities
In January 2015, we issued $600 million of 3.40% senior unsecured notes due 2025. The notes were priced at 99.185% of the principal amount with a yield-to-maturity of 3.497%. Net proceeds were used to repay the entire $105 million U.S. dollar amount outstanding on our revolving credit facility at closing and $200 million of 6.00% senior unsecured notes that matured on March 1, 2015. We intend to use the remaining proceeds to repay $200 million of 7.00% senior unsecured notes maturing in June 2015 and for general corporate purposes.
In January 2015, to economically hedge a portion of our foreign currency risk from the HC-One Facility, we completed a £220 million four-year unsecured term loan that accrues interest at GBP LIBOR plus 0.975%, subject to adjustments based on our credit ratings. Concurrently, we entered into a three-year interest rate swap agreement that fixes the rate of the term loan at 1.79%, and a foreign currency swap agreement that fixes the GBP/USD exchange rate at 1.5149 on interest income from the HC-One debt investment in excess of interest payments on the term loan. Proceeds from this term loan repaid £220 million of the GBP balance drawn on our revolving credit facility that were used to fund our HC-One debt investment in November 2014.
Dividends
On April 30, 2015, we announced that our Board declared a quarterly common stock cash dividend of $0.565 per share. The common stock dividend will be paid on May 26, 2015 to stockholders of record as of the close of business on May 11, 2015.
Results of Operations
We evaluate our business and allocate resources among our business segments: (i) senior housing, (ii) post-acute/skilled nursing, (iii) life science, (iv) medical office and (v) hospital. Under the senior housing, post-acute/skilled nursing, life science and hospital segments, we primarily invest, through the acquisition and development, in single operator or tenant properties and debt issued by operators in these sectors. Under the medical office segment, we invest, through the acquisition and development, in single or multi-tenant medical office buildings (“MOBs”), which generally require a greater level of property management.
Non-GAAP Financial Measures
Net Operating Income (“NOI”)
NOI and adjusted NOI are non-GAAP supplemental financial measures used to evaluate the operating performance of real estate. NOI is defined as rental and related revenues, including tenant recoveries, resident fees and services, and income from direct financing leases (“DFLs”), less property level operating expense; NOI excludes all other financial statement amounts included in net (loss) income as presented in Note14 to the Consolidated Financial Statements. Management believes NOI provides relevant and useful information because it reflects only income and operating expense items that are incurred at the property level and presents them on an unleveraged basis. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL accretion, amortization of market lease intangibles and lease termination fees. Adjusted NOI is oftentimes referred to as “cash NOI.” We use NOI and adjusted NOI to make decisions about resource allocations and to assess and compare property level performance. We believe that net (loss) income is the most directly comparable GAAP measure to NOI. NOI should not be viewed as an alternative measure of operating performance to net (loss) income as defined by GAAP because it does not reflect various excluded items. Further, our definition of NOI may not be comparable to the definition used by other REITs or real estate companies, as those companies may use different methodologies for calculating NOI. NOI and adjusted NOI are non-GAAP supplemental financial measures; for a reconciliation of net (loss) income to NOI and adjusted NOI and other relevant disclosure, refer to Note 14 to the Consolidated Financial Statements.
Operating expenses generally relate to leased medical office and life science properties and senior housing RIDEA properties. We generally recover all or a portion of our leased medical office and life science property expenses through tenant recoveries. We present expenses as operating or general and administrative based on the underlying nature of the expense. Periodically, we review the classification of expenses between categories and make revisions based on changes in the underlying nature of the expenses.
Same Property Portfolio (“SPP”)
Our evaluation of results of operations by each business segment includes an analysis of NOI and adjusted NOI of our SPP and our total property portfolio. We believe NOI provides relevant and useful information because it reflects only income and operating expense items that are incurred at the property level and presents them on an unleveraged basis. We use NOI and adjusted NOI to make decisions about resource allocations and to assess and compare property level performance. SPP NOI and adjusted NOI information allows us to evaluate the performance of our property portfolio under a consistent population by eliminating changes in the composition of our portfolio of properties. We identify our SPP as stabilized properties that remained in operations and were consistently reported as leased properties or RIDEA properties for the duration of the year over year comparison periods presented. Accordingly, it takes a stabilized property a minimum of 12 months in operations under a consistent reporting structure to be included in our SPP. Newly acquired operating assets are generally considered stabilized at the earlier of lease up (typically when the tenant(s) controls the physical use of at least 80% of the space) or 12 months from the acquisition date. Newly completed developments and redevelopments are considered stabilized at the earlier of lease up or 24 months from the date the property is placed in service. SPP NOI excludes certain non-property specific operating expenses that are allocated to each operating segment on a consolidated basis. A property is removed from our SPP when it is sold, placed into redevelopment or contributed to partnerships under a RIDEA structure.
Funds From Operations (“FFO”)
We believe FFO applicable to common shares, diluted FFO applicable to common shares, and diluted FFO per common share are important supplemental non-GAAP measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets utilizes straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen and fallen with market conditions, presentations of operating results for a REIT that use historical cost accounting for depreciation could be less informative. The term FFO was designed by the REIT industry to address this issue.
FFO as defined by the National Association of Real Estate Investment Trusts (“NAREIT”) is net (loss) income applicable to common shares (computed in accordance with GAAP), excluding gains or losses from sales of property, impairments of, or related to, depreciable real estate, plus real estate and DFL depreciation and amortization, and after adjustments for joint ventures. Adjustments for joint ventures are calculated to reflect FFO on the same basis. FFO does not represent cash generated from operating activities in accordance with GAAP, is not necessarily indicative of cash available to fund cash needs and should not be considered an alternative to net (loss) income. We compute FFO in accordance with the current NAREIT definition; however, other REITs may report FFO differently or have a different interpretation of the current NAREIT definition from ours.
In addition, we present FFO before the impact of severance related charges, litigation settlement charges, preferred stock redemption charges, impairments (recoveries) of non-depreciable assets and transaction-related items (defined below) (“FFO as adjusted”). Transaction-related items include acquisition and pursuit costs (e.g., due diligence and closing) and gains/charges incurred as a result of mergers and acquisitions and lease amendment or termination activities. Management believes that FFO as adjusted provides a meaningful supplemental measurement of our FFO run-rate. This measure is a modification of the NAREIT definition of FFO and should not be used as an alternative to net (loss) income (determined in accordance with GAAP) or NAREIT FFO. FFO and FFO as adjusted are non-GAAP supplemental financial measures; for a reconciliation of net (loss) income to FFO and FFO as adjusted and other relevant disclosure, refer to “Non-GAAP Financial Measures Reconciliations” below.
Funds Available for Distribution (“FAD”)
FAD is defined as FFO as adjusted after excluding the impact of the following: (i) amortization of acquired market lease intangibles, net; (ii) amortization of deferred compensation expense; (iii) amortization of deferred financing costs, net; (iv) straight-line rents; (v) accretion and depreciation related to DFLs and lease incentive amortization (reduction of straight-line rents); and (vi) deferred revenues, excluding amounts amortized into rental income that are associated with tenant funded improvements owned/recognized by us and up-front cash payments made by tenants to reduce their contractual rents. Also, FAD is: (i) computed after deducting recurring capital expenditures, including leasing costs and second generation tenant and capital improvements; and (ii) includes lease restructure payments and adjustments to compute our share of FAD from our unconsolidated joint ventures and those related to CCRC non-refundable entrance fees. Other REITs or real estate companies may use different methodologies for calculating FAD, and accordingly, our FAD may not be comparable to those reported by other REITs. Although our FAD computation may not be comparable to that of other REITs, management believes FAD provides a meaningful supplemental measure of our performance and is frequently used by analysts, investors, and other interested parties in the evaluation of our performance as a REIT. FAD does not represent cash generated from operating activities determined in accordance with GAAP, is not necessarily indicative of cash available to fund cash needs, and should not be considered as an alternative to net (loss) income determined in accordance with GAAP. FAD is a non-GAAP supplemental financial measure; for a reconciliation of net (loss) income to FAD, as defined, and other relevant disclosure, refer to “Non-GAAP Financial Measures Reconciliations” below.
Comparison of the Three Months Ended March 31, 2015 to the Three Months Ended March 31, 2014
Overview(1)
Results are for the three months ended March 31, 2015 and 2014 (dollars in thousands except per share data):
| Three Months Ended March 31, 2015 Amount | Per Share | Three Months Ended March 31, 2014 Amount | Per Share | Per Share Change | |
|---|---|---|---|---|---|
| FFO | $(117,572) | $(0.26) | $343,139 | $0.75 | $(1.01) |
| FFO as adjusted | 364,282 | 0.79 | 343,634 | 0.75 | 0.04 |
| FAD | 319,581 | 0.69 | 287,516 | 0.63 | 0.06 |
| Net (loss) income applicable to common shares | (240,949) | (0.52) | 258,047 | 0.56 | (1.08) |
(1) For the reconciliation, see “Non-GAAP Financial Measures Reconciliations” section below.
FFO as adjusted and FAD increased $0.04 and $0.06 per share, respectively, primarily as a result of increased NOI from our SPP, 2014 acquisitions and incremental interest income from the repayment of a development loan resulting from our share in the appreciation of the underlying real estate asset.
FFO and earnings per share ("EPS") decreased primarily as a result of a $478 million impairment related to our DFL investments with HCRMC, partially offset by the aforementioned events impacting FFO as adjusted and FAD.
Segment NOI and Adjusted NOI
The tables below provide selected operating information for our SPP and total property portfolio for each of our business segments. Our consolidated SPP consists of 1,011 properties representing properties acquired or placed in service and stabilized on or prior to January 1, 2014 and that remained in operations under a consistent reporting structure through March 31, 2015. Our consolidated total property portfolio represents 1,101 and 1,080 properties at March 31, 2015 and 2014, respectively, and excludes properties that were sold.
Results are as of and for the three months ended March 31, 2015 and 2014 (dollars and square feet in thousands except per capacity data):
Senior Housing
| SPP Three Months Ended March 31, 2015 | 2014 | Change | Total Portfolio Three Months Ended March 31, 2015 | 2014 | Change | |
|---|---|---|---|---|---|---|
| Rental revenues(1) | $124,266 | $124,762 | $(496) | $127,382 | $150,085 | $(22,703) |
| Resident fees and services | 39,269 | 38,048 | 1,221 | 105,013 | 38,053 | 66,960 |
| Total segment revenues | 163,535 | 162,810 | 725 | 232,395 | 188,138 | 44,257 |
| Operating expenses | (24,344) | (24,028) | (316) | (75,510) | (24,548) | (50,962) |
| NOI | 139,191 | 138,782 | 409 | 156,885 | 163,590 | (6,705) |
| Straight-line rents | (4,657) | (9,090) | 4,433 | (5,040) | (10,524) | 5,484 |
| DFL accretion | (2,323) | (2,544) | 221 | (2,323) | (2,544) | 221 |
| Amortization of above and below market lease intangibles, net | (153) | (153) | — | (153) | (147) | (6) |
| Lease termination fees | — | — | — | 1,103 | — | 1,103 |
| Adjusted NOI | $132,058 | $126,995 | $5,063 | $150,472 | $150,375 | $97 |
| Adjusted NOI % change | 4.0% | |||||
| Property count(2) | 383 | 383 | 458 | 444 | ||
| Average capacity (units)(3) | 38,363 | 38,393 | 44,908 | 45,560 | ||
| Average annual rent per unit(4) | $13,808 | $13,272 | $13,481 | $13,283 |
(1) Represents rental and related revenues and income from DFLs.
(2) From our past presentation of SPP for the three months ended March 31, 2014, we removed eight senior housing properties from SPP that were sold and 51 senior housing properties that were contributed to partnerships under a RIDEA structure as part of the 2014 Brookdale Transaction and no longer meet our criteria for SPP as of the date of contribution.
(3) Represents average capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented.
(4) Average annual rent per unit for RIDEA properties is based on NOI.
SPP Adjusted NOI. SPP adjusted NOI improved as a result of annual rent increases and improved performance from RIDEA properties.
Total Portfolio NOI. Our total portfolio NOI decreased primarily as a result of contributing three assets into the CCRC JV in August 2014 and the sale of eight assets in January 2015 as part of the 2014 Brookdale Transaction (see Note 3 to the Consolidated Financial Statements), partially offset by the impact from our SPP and senior housing acquisitions in 2014.
Post-Acute/Skilled Nursing
| SPP Three Months Ended March 31, 2015 | 2014 | Change | Total Portfolio Three Months Ended March 31, 2015 | 2014 | Change | |
|---|---|---|---|---|---|---|
| Rental revenues(1) | $140,357 | $137,310 | $3,047 | $140,576 | $137,780 | $2,796 |
| Operating expenses | (79) | (73) | (6) | (533) | (532) | (1) |
| NOI | 140,278 | 137,237 | 3,041 | 140,043 | 137,248 | 2,795 |
| Straight-line rents | (97) | (282) | 185 | (113) | (282) | 169 |
| DFL accretion | (17,981) | (18,831) | 850 | (17,981) | (18,878) | 897 |
| Amortization of above and below market lease intangibles, net | 11 | 11 | — | 11 | 11 | — |
| Adjusted NOI | $122,211 | $118,135 | $4,076 | $121,960 | $118,099 | $3,861 |
| Adjusted NOI % change | 3.5% | |||||
| Property count(2) | 301 | 301 | 301 | 302 | ||
| Average capacity (beds)(3) | 38,282 | 38,279 | 38,282 | 38,464 | ||
| Average annual rent per bed | $12,777 | $12,351 | $12,798 | $12,336 |
(1) Represents rental and related revenues and income from DFLs.
(2) From our past presentation of SPP for the three months ended March 31, 2014, we removed a post-acute/skilled nursing property from SPP that was sold.
(3) Represents average capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented.
NOI and Adjusted NOI. SPP and total portfolio NOI and adjusted NOI increased primarily as a result of annual rent escalations from our HCRMC DFL investments.
See “2015 Transaction Overview” above for further discussion of developments with HCRMC.
During the quarter ended March 31, 2015 we recorded a net impairment charge of $478 million related to our DFL investments with HCRMC. The impairment charge reduced the carrying value of the HCRMC DFL investments from $6.6 billion to $6.1 billion. The impairment determination resulted from recent discussions with HCRMC in which they expressed an increasing desire to reduce rent in consideration of potential economic trades to HCP prior to the April 1, 2015 rental increase of 3.5% under the Master Lease (without regard to the HCRMC Lease Amendment). HCRMC indicated that they sought an amendment of the Master Lease to provide financial flexibility to meet the reimbursement and competitive challenges they face in operating and growing their business, and to remove any uncertainty that could result from any further deterioration in their operating results and corresponding ability to remain in compliance with the covenants under their credit facilities.
See Note 6 to the Consolidated Financial Statements for additional discussion on the HCRMC Lease Amendment and the impairment of our HCRMC DFL investment. The DOJ filed a complaint against HCRMC that was released from seal on April 20, 2015 (see Note 8 to the Consolidated Financial Statements).
Life Science
| SPP Three Months Ended March 31, 2015 | 2014 | Change | Total Portfolio Three Months Ended March 31, 2015 | 2014 | Change | |
|---|---|---|---|---|---|---|
| Rental and related revenues | $64,852 | $61,905 | $2,947 | $69,504 | $64,781 | $4,723 |
| Tenant recoveries | 12,811 | 10,871 | 1,940 | 14,047 | 11,341 | 2,706 |
| Total segment revenues | 77,663 | 72,776 | 4,887 | 83,551 | 76,122 | 7,429 |
| Operating expenses | (13,983) | (12,493) | (1,490) | (16,699) | (14,161) | (2,538) |
| NOI | 63,680 | 60,283 | 3,397 | 66,852 | 61,961 | 4,891 |
| Straight-line rents | (2,637) | (2,322) | (315) | (3,159) | (2,580) | (579) |
| Amortization of above and below market lease intangibles, net | 52 | (1) | 53 | 84 | 18 | 66 |
| Lease termination fees | — | — | — | — | (570) | 570 |
| Adjusted NOI | $61,095 | $57,960 | $3,135 | $63,777 | $58,829 | $4,948 |
| Adjusted NOI % change | 5.4% | |||||
| Property count(1) | 106 | 106 | 111 | 111 | ||
| Average occupancy | 96.3% | 91.0% | 96.2% | 91.1% | ||
| Average occupied square feet | 6,616 | 6,240 | 7,046 | 6,411 | ||
| Average annual total segment revenues per occupied square foot | $45 | $45 | $46 | $46 | ||
| Average annual base rent per occupied square foot | $38 | $38 | $38 | $38 |
(1) From our past presentation of SPP for the three months ended March 31, 2014, we removed a life science facility from SPP that was placed into land held for development and a life science facility that was placed into redevelopment in 2014, which no longer meet our criteria for SPP as of the date placed into development or redevelopment.
SPP NOI and Adjusted NOI. SPP NOI and adjusted NOI increased primarily as a result of increased occupancy. Additionally, SPP adjusted NOI increased as a result of annual rent escalations.
Total Portfolio NOI and Adjusted NOI. In addition to the impact of our SPP, our total portfolio NOI and adjusted NOI increased primarily as a result of the impact of our life science development projects placed into service during 2014.
During the three months ended March 31, 2015, 215,000 square feet of new and renewal leases commenced at an average annual base rent of $37.24 per square foot compared to 119,000 square feet of expiring leases with an average annual base rent of $29.01 per square foot.
Medical Office
| SPP Three Months Ended March 31, 2015 | 2014 | Change | Total Portfolio Three Months Ended March 31, 2015 | 2014 | Change | |
|---|---|---|---|---|---|---|
| Rental and related revenues | $75,450 | $75,051 | $399 | $83,119 | $75,765 | $7,354 |
| Tenant recoveries | 13,504 | 13,420 | 84 | 15,186 | 13,497 | 1,689 |
| Total segment revenues | 88,954 | 88,471 | 483 | 98,305 | 89,262 | 9,043 |
| Operating expenses | (33,688) | (33,498) | (190) | (38,252) | (35,516) | (2,736) |
| NOI | 55,266 | 54,973 | 293 | 60,053 | 53,746 | 6,307 |
| Straight-line rents | (1,156) | (999) | (157) | (1,829) | (1,002) | (827) |
| Amortization of above and below market lease intangibles, net | 164 | 271 | (107) | 23 | 293 | (270) |
| Lease termination fees | (60) | (8) | (52) | (60) | (8) | (52) |
| Adjusted NOI | $54,214 | $54,237 | $(23) | $58,187 | $53,029 | $5,158 |
| Adjusted NOI % change | —% | |||||
| Property count(1) | 205 | 205 | 215 | 207 | ||
| Average occupancy | 90.5% | 91.4% | 90.2% | 90.9% | ||
| Average occupied square feet | 12,642 | 12,762 | 13,750 | 12,861 | ||
| Average annual total segment revenues per occupied square foot | $28 | $27 | $28 | $27 | ||
| Average annual base rent per occupied square foot | $23 | $23 | $24 | $23 |
(1) From our past presentation of SPP for the three months ended March 31, 2014, we removed a MOB from SPP that was sold.
Total Portfolio NOI and Adjusted NOI. Our total portfolio NOI and adjusted NOI increased primarily as a result of the impact of our medical office acquisitions in 2014.
During the three months ended March 31, 2015, 388,000 square feet of new and renewal leases commenced at an average annual base rent of $25.91 per square foot compared to 451,000 square feet of expiring and terminated leases with an average annual base rent of $26.81 per square foot.
Hospital
| SPP Three Months Ended March 31, 2015 | 2014 | Change | Total Portfolio Three Months Ended March 31, 2015 | 2014 | Change | |
|---|---|---|---|---|---|---|
| Rental revenues(1) | $21,567 | $20,935 | $632 | $21,580 | $20,948 | $632 |
| Tenant recoveries | 662 | 597 | 65 | 662 | 597 | 65 |
| Total segment revenues | 22,229 | 21,532 | 697 | 22,242 | 21,545 | 697 |
| Operating expenses | (1,037) | (947) | (90) | (1,037) | (950) | (87) |
| NOI | 21,192 | 20,585 | 607 | 21,205 | 20,595 | 610 |
| Straight-line rents | 594 | 408 | 186 | 594 | 408 | 186 |
| Amortization of above and below market lease intangibles, net | (342) | (342) | — | (342) | (342) | — |
| Adjusted NOI | $21,444 | $20,651 | $793 | $21,457 | $20,661 | $796 |
| Adjusted NOI % change | 3.8% | |||||
| Property count | 16 | 16 | 16 | 16 | ||
| Average capacity (beds)(2) | 2,221 | 2,221 | 2,221 | 2,221 | ||
| Average annual rent per bed | $40,488 | $38,898 | $40,511 | $38,921 |
(1) Represents rental and related revenues and income from DFLs.
(2) Represents capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented. Certain operators in our hospital portfolio are not required under their respective leases to provide operational data.
NOI and Adjusted NOI. SPP and total portfolio NOI and adjusted NOI increased primarily as a result of additional rents earned in 2015 due to exceeding pre-established thresholds and annual rent escalations.
Other Income and Expense Items
Interest income
Interest income increased $17 million to $33 million for the three months ended March 31, 2015. The increase was primarily the result of income from our HC-One Facility in November 2014 and February 2015 (see Note 7 to the Consolidated Financial Statements) and incremental interest income from the repayment of a development loan resulting from the appreciation of the underlying real estate asset.
Interest expense
Interest expense increased $10 million to $117 million for the three months ended March 31, 2015. The increase was primarily the result of: (i) our senior unsecured notes offerings during 2014 and 2015, (ii) increased borrowings from our term loan originated in 2015, (iii) increased borrowings under our line of credit facility and (iv) lower capitalized interest. The increases in interest expense were partially offset by repayments of senior unsecured notes and mortgage debt that matured during 2014 and 2015.
Our exposure to expense fluctuations related to our variable rate indebtedness is substantially mitigated by our interest rate swap contracts. For a more detailed discussion of our interest rate risk, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 3.
The table below sets forth information with respect to our debt, excluding premiums and discounts (dollars in thousands):
| Balance: | As of March 31, (1) 2015 | 2014 |
|---|---|---|
| Fixed rate | $9,553,025 | $8,371,372 |
| Variable rate | 367,055 | 33,955 |
| Total | $9,920,080 | $8,405,327 |
| Percent of total debt: | ||
| Fixed rate | 96.3% | 99.6% |
| Variable rate | 3.7% | 0.4% |
| Total | 100.0% | 100.0% |
| Weighted average interest rate at end of period: | ||
| Fixed rate | 4.80% | 5.16% |
| Variable rate | 1.70% | 1.15% |
| Total | 4.68% | 5.14% |
(1) At March 31, 2015, excludes $96 million of other debt that represents non-interest bearing life care bonds and occupancy fee deposits at certain of our senior housing facilities and demand notes that have no scheduled maturities. At March 31, 2014, excludes $74 million of other debt that represents non-interest bearing life care bonds and occupancy fee deposits at certain of our senior housing facilities. At March 31, 2015 and 2014, $71 million and $72 million, respectively, of variable-rate mortgages and £357 million and £137 million ($530 million and $228 million), respectively, of term loans are presented as fixed-rate debt as the interest payments were swapped from variable to fixed.
Depreciation and amortization expense
Depreciation and amortization expense increased $7 million to $115 million for the three months ended March 31, 2015. The increase was primarily the result of the impact of our acquisitions and redevelopment projects placed in service during 2014.
General and administrative expenses
General and administrative expenses increased $4 million to $25 million for the three months ended March 31, 2015. The increase was primarily the result of higher compensation expenses.
Acquisition and pursuit costs
Acquisition and pursuit costs increased $3 million to $3 million for the three months ended March 31, 2015. The increase was primarily due to higher levels of transactional activity in 2015. Acquisition and pursuit costs were previously included in general and administrative expenses.
Impairments
During the three months ended March 31, 2015, we recognized an impairment charge of $478 million related to our DFL investments with HCRMC (see Note 6 to the Consolidated Financial Statements).
Equity income from unconsolidated joint ventures
Equity income from unconsolidated joint ventures decreased $1 million to $14 million for the three months ended March 31, 2015. The decrease was primarily the result of our share of losses recognized from our CCRC JV, partially offset by an increase in our share of earnings from our HCRMC investment.
Gain on sales of real estate
During the three months ended March 31, 2015, we sold eight senior housing facilities and recognized gains of $6 million. During the three months ended March 31, 2014, we sold two post-acute/skilled nursing facilities and a hospital and recognized gains of $28 million.
Liquidity and Capital Resources
During the three months ended March 31, 2015, distributions to stockholders and noncontrolling interest holders exceeded cash flows from operations by approximately $35 million, which was funded by cash on hand. We anticipate satisfying our distributions to our stockholders and non-controlling interest members for the next 12 months by primarily using cash flow from operations and available cash balances. Additionally, we expect to meet our scheduled financing maturities for 2015 (excluding future acquisitions) with the proceeds from our January 2015 $600 million senior unsecured note offering.
Our principal investing liquidity needs for the next 12 months are to:
- fund capital expenditures, including tenant improvements and leasing costs; and
- fund future acquisition, transactional and development activities
We anticipate satisfying these future investing needs using one or more of the following:
- issuance of common or preferred stock;
- issuance of additional debt, including unsecured notes and mortgage debt;
- draws on our credit facilities; and/or
- sale or exchange of ownership interests in properties.
Access to capital markets impacts our cost of capital and ability to refinance maturing indebtedness, as well as our ability to fund future acquisitions and development through the issuance of additional securities or secured debt. Credit ratings impact our ability to access capital and directly impact our cost of capital as well. For example, as noted below, our revolving line of credit facility accrues interest at a rate per annum equal to LIBOR plus a margin that depends upon our credit ratings. We also pay a facility fee on the entire revolving commitment that depends upon our credit ratings. As of April 30, 2015, we had a credit rating of BBB+ from Fitch, Baa1 from Moody’s and BBB+ from S&P on our senior unsecured debt securities.
Cash Flow Summary
The following summary discussion of our cash flows is based on the consolidated statements of cash flows and is not meant to be an all-inclusive discussion of the changes in our cash flows for the periods presented below.
Cash and cash equivalents were $137 million and $184 million at March 31, 2015 and December 31, 2014, respectively, representing a decrease of $47 million. The following table sets forth changes in cash flows (dollars in thousands):
| Three Months Ended March 31, 2015 | 2014 | Change | |
|---|---|---|---|
| Net cash provided by operating activities | $230,068 | $247,181 | $(17,113) |
| Net cash used in investing activities | (328,286) | (46,551) | (281,735) |
| Net cash provided by (used in) financing activities | 51,722 | (451,450) | 503,172 |
The decrease in operating cash flows is primarily the result of the following: increases in accounts receivables and other assets, and decreases in accounts payable and accrued liabilities. The decreases in operating cash flows were partially offset by increases as a result of (i) the impact from our investments, (ii) redevelopment assets placed in service and (iii) rent escalations and resets. Our cash flows from operations are dependent upon the occupancy levels of our buildings, rental rates on leases, our tenants’ performance on their lease obligations, the level of operating expenses and other factors.
The following are significant investing and financing activities for the three months ended March 31, 2015:
- made investments of $349 million (development and acquisition of real estate, and investments in unconsolidated joint ventures and loans);
- paid dividends on common stock of $261 million, which were generally funded by cash provided by our operating activities and cash on hand; and
- raised proceeds of $991 million primarily from sales of senior unsecured notes, borrowings under the term loan originated in January 2015 and issuances of common stock; and repaid $662 million of borrowings under our bank line of credit, senior unsecured notes and mortgages.
Debt
Bank Line of Credit and Term Loan
Our $2.0 billion unsecured revolving line of credit facility (the “Facility”) matures on March 31, 2018 and contains a one-year extension option. Borrowings under the Facility accrue interest at LIBOR plus a margin that depends upon our debt ratings. We pay a facility fee on the entire revolving commitment that depends on its debt ratings. Based on our debt ratings at April 30, 2015, the margin on the Facility was 0.925%, and the facility fee was 0.15%. The Facility also includes a feature that will allow us to increase the borrowing capacity by an aggregate amount of up to $500 million, subject to securing additional commitments from existing lenders or new lending institutions. At March 31, 2015, we had £242 million ($359 million) outstanding under the Facility with a weighted average effective interest rate of 1.72%.
On January 12, 2015, we entered into a credit agreement with a syndicate of banks for a £220 million ( $327 million at March 31, 2015) four-year unsecured term loan (the “2015 Term Loan”) that accrues interest at a rate of GBP LIBOR plus 0.975%, subject to adjustments based on our credit ratings. Proceeds from this term loan were used to repay £220 million draw on the Facility to fund the November 2014 HC-One debt investment (see Note 7). Concurrently, we entered into a three-year interest rate swap agreement that effectively fixes the interest rate of the 2015 Term Loan at 1.79% (see Note 20). The 2015 Term Loan contains a one-year committed extension option.
The Facility and term loans contain certain financial restrictions and other customary requirements. Among other things, these covenants, using terms defined in the agreements, (i) limit the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value to 60%, (ii) limit the ratio of Secured Debt to Consolidated Total Asset Value to 30%,
(iii) limit the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value to 60% and (iv) require a minimum Fixed Charge Coverage ratio of 1.5 times. The Facility and Term Loans also require a Minimum Consolidated Tangible Net Worth of $9.5 billion at March 31, 2015. At March 31, 2015, we were in compliance with each of these restrictions and requirements of the Facility and Term Loans.
Senior Unsecured Notes
At March 31, 2015, we had senior unsecured notes outstanding with an aggregate principal balance of $8.1 billion. Interest rates on the notes ranged from 2.79% to 6.99% with a weighted average effective interest rate of 4.82% and a weighted average maturity of six years at March 31, 2015. The senior unsecured notes contain certain covenants including limitations on debt, maintenance of unencumbered assets, cross-acceleration provisions and other customary terms. We believe we were in compliance with these covenants at March 31, 2015.
Mortgage Debt
At March 31, 2015, we had $981 million in aggregate principal amount of mortgage debt outstanding is secured by 70 healthcare facilities (including redevelopment properties), which have a carrying value of $1.3 billion. Interest rates on the mortgage debt ranged from 0.42% to 8.38% with a weighted average effective interest rate of 6.15% and a weighted average maturity of three years at March 31, 2015.
Mortgage debt generally requires monthly principal and interest payments, is collateralized by real estate assets and is generally non-recourse. Mortgage debt typically restricts transfer of the encumbered assets, prohibits additional liens, restricts prepayment, requires payment of real estate taxes, requires maintenance of the assets in good condition, requires maintenance of insurance on the assets, and includes conditions to obtain lender consent to enter into and terminate material leases. Some of the mortgage debt is also cross-collateralized by multiple assets and may require tenants or operators to maintain compliance with the applicable leases or operating agreements of such real estate assets.
Equity
At March 31, 2015, we had 462 million shares of common stock outstanding. At March 31, 2015, equity totaled $10.6 billion and our equity securities had a market value of $20.2 billion.
At March 31, 2015, non-managing members held an aggregate of 4 million units in five limited liability companies (“DownREITs”) for which we are the managing member. The DownREIT units are exchangeable for an amount of cash approximating the then-current market value of shares of our common stock or, at our option, shares of our common stock (subject to certain adjustments, such as stock splits and reclassifications).
Capital Market Outlook
The capital markets have facilitated our continued growth, including our international expansion. For the 15 months ended March 31, 2015, we have raised $1.75 billion in senior unsecured notes, originated a £220 million ($333 million) four-year unsecured term loan and increased our Facility from $1.5 to $2.0 billion. The capital raised, in combination with available cash and borrowing capacity under our Facility, supported $2.1 billion and $332 million of investments completed during the year ended December 31, 2014 and three months ended March 31, 2015, respectively. We believe our equity and debt investors, as well as our banking relationships, will provide additional capital as we pursue new investment opportunities.
Shelf Registration
We have a prospectus that we filed with the U.S. Securities and Exchange Commission (the “SEC”) as part of a registration statement on Form S-3ASR, using a shelf registration process which expires in July 2015. Under the “shelf” process, we may sell any combination of the securities described in the prospectus in one or more offerings. The securities described in the prospectus include common stock, preferred stock, depositary shares, debt securities and warrants.
Contractual Obligations
The following table summarizes our material contractual payment obligations and commitments at March 31, 2015 (in thousands):
| Total(1) | Less than One Year | 2016-2017 | 2018-2019 | More than Five Years | |
|---|---|---|---|---|---|
| Bank line of credit(2) | $358,555 | $— | $— | $358,555 | $— |
| Term loans(3) | 530,038 | — | 203,404 | 326,634 | — |
| Senior unsecured notes | 8,050,000 | 200,000 | 1,650,000 | 1,050,000 | 5,150,000 |
| Mortgage debt | 981,487 | 35,549 | 874,113 | 8,655 | 63,170 |
| Construction loan commitments(4) | 7,891 | 7,891 | — | — | — |
| Development commitments(5) | 129,365 | 108,020 | 21,345 | — | — |
| Ground and other operating leases | 249,391 | 5,437 | 12,985 | 12,142 | 218,827 |
| HCP Ventures IV support commitment | 114,220 | — | 114,220 | — | — |
| Interest(6) | 2,594,490 | 270,305 | 758,281 | 491,710 | 1,074,194 |
| Total | $13,015,437 | $627,202 | $3,634,348 | $2,247,696 | $6,506,191 |
(1) Excludes $96 million of other debt that represents Life Care Bonds and Demand Notes that have no scheduled maturities.
(2) Represents £242 million translated into U.S. dollars.
(3) Represents £357 million translated into U.S. dollars.
(4) Represents commitments to finance development projects and related working capital.
(5) Represents construction and other commitments for developments in progress.
(6) Interest on variable-rate debt is calculated using rates in effect at March 31, 2015.
Off-Balance Sheet Arrangements
We own interests in certain unconsolidated joint ventures as described under Note 8 to the Consolidated Financial Statements. Except in limited circumstances, our risk of loss is limited to our investment in the joint venture and any outstanding loans receivable (see Note 17 to the Consolidated Financial Statements). In addition, we have certain properties which serve as collateral for debt that is owed by a previous owner of certain of our facilities. Our risk of loss for these certain properties is limited to the outstanding debt balance plus penalties, if any. We have no other material off-balance sheet arrangements that we expect would materially affect our liquidity and capital resources except those described below under “Contractual Obligations.”
Inflation
Our leases often provide for either fixed increases in base rents or indexed escalators, based on the Consumer Price Index or other measures, and/or additional rent based on increases in the tenants’ operating revenues. Most of our MOB leases require the tenant to pay a share of property operating costs such as real estate taxes, insurance and utilities. Substantially all of our senior housing, life science, post-acute/skilled nursing and hospital leases require the operator or tenant to pay all of the property operating costs or reimburse us for all such costs. We believe that inflationary increases in expenses will be offset, in part, by the operator or tenant expense reimbursements and contractual rent increases described above.
Non-GAAP Financial Measures Reconciliations
Funds From Operations and Funds Available for Distribution
The following is a reconciliation from net (loss) income applicable to common shares, the most directly comparable financial measure calculated and presented in accordance with GAAP, to FFO, FFO as adjusted and FAD (in thousands, except per share data):
| Three Months Ended March 31, 2015 | 2014 | |
|---|---|---|
| Net (loss) income applicable to common shares | $(240,949) | $258,047 |
| Depreciation and amortization of real estate, in-place lease and other intangibles | 114,522 | 107,388 |
| Other depreciation and amortization | 6,684 | 3,846 |
| Gain on sales of real estate | (6,264) | (28,010) |
| Equity income from unconsolidated joint ventures | (13,601) | (14,528) |
| FFO from unconsolidated joint ventures | 24,849 | 16,961 |
| Noncontrolling interests’ and participating securities’ share in earnings | 3,446 | 5,576 |
| Noncontrolling interests’ and participating securities’ share in FFO | (6,259) | (6,141) |
| FFO applicable to common shares | (117,572) | 343,139 |
| Distributions on dilutive convertible units | — | 3,420 |
| Diluted FFO applicable to common shares | $(117,572) | $346,559 |
| Diluted FFO per common share | $(0.26) | $0.75 |
| Weighted average shares used to calculate diluted FFO per common share | 460,880 | 463,661 |
47
| Three Months Ended March 31, 2015 | 2014 | |
|---|---|---|
| Net (loss) income applicable to common shares | $(0.52) | $0.56 |
| Depreciation and amortization of real estate, in-place lease and other intangibles | 0.25 | 0.23 |
| Other depreciation and amortization | 0.01 | 0.01 |
| Gain on sales of real estate | (0.01) | (0.06) |
| Joint venture and participating securities FFO adjustments | 0.01 | 0.01 |
| Diluted FFO applicable to common shares | $(0.26) | $0.75 |
| Impact of adjustments to FFO: | ||
| Other impairment(1) | $478,464 | $— |
| Transaction-related items(2) | 3,390 | 495 |
| $481,854 | $495 | |
| FFO as adjusted applicable to common shares | $364,282 | $343,634 |
| Distributions on dilutive convertible units and other | 3,194 | 3,420 |
| Diluted FFO as adjusted applicable to common shares | $367,476 | $347,054 |
| Diluted FFO as adjusted per common share | $0.79 | $0.75 |
| Weighted average shares used to calculate diluted FFO as adjusted per common share | 467,229 | 463,661 |
48
| Three Months Ended March 31, 2015 | 2014 | |
|---|---|---|
| FFO as adjusted applicable to common shares | $364,282 | $343,634 |
| Amortization of market lease intangibles, net | (378) | (168) |
| Amortization of deferred compensation | 6,165 | 4,890 |
| Amortization of deferred financing costs, net | 4,752 | 4,965 |
| Straight-line rents | (9,546) | (13,968) |
| DFL accretion(3) | (20,304) | (21,422) |
| Other depreciation and amortization | (6,684) | (3,846) |
| Deferred revenues – tenant improvement related | (744) | (482) |
| Deferred revenues – additional rents | (158) | 337 |
| Leasing costs and tenant and capital improvements | (11,540) | (12,405) |
| Lease restructure payments | 5,135 | — |
| Joint venture adjustments – CCRC entrance fees | 6,193 | — |
| Joint venture and other FAD adjustments(3) | (17,592) | (14,019) |
| FAD applicable to common shares | $319,581 | $287,516 |
| Distributions on dilutive convertible units | 3,568 | 2,251 |
| Diluted FAD applicable to common shares | $323,149 | $289,767 |
| Diluted FAD per common share | $0.69 | $0.63 |
| Weighted average shares used to calculate diluted FAD per common share | 467,229 | 461,804 |
(1) The other impairment charge of $478 million relates to our DFL investments with HCRMC.
(2) Transaction-related items include acquisition and pursuit costs (e.g., due diligence and closing) and gains/charges incurred as a result of mergers and acquisitions and lease amendment or termination activities.
(3) Our ownership interest in HCRMC is accounted for using the equity method, which requires an ongoing elimination of DFL income that is proportional to our ownership in HCRMC. Further, our share of earnings from HCRMC (equity income) increases for the corresponding elimination of related lease expense recognized at the HCRMC entity level, which we present as a non-cash joint venture FAD adjustment.
Critical Accounting Policies
The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to use judgment in the application of accounting policies, including making estimates and assumptions. We base estimates on the best information available to us at the time, our experience and on various other assumptions believed to be reasonable under the circumstances. These estimates affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. If our judgment or interpretation of the facts and circumstances relating to various transactions or other matters had been different, it is possible that different accounting would have been applied, resulting in a different presentation of our consolidated financial statements. From time to time, we re-evaluate our estimates and assumptions. In the event estimates or assumptions prove to be different from actual results, adjustments are made in subsequent periods to reflect more current estimates and assumptions about matters that are inherently uncertain. A summary of our critical accounting policies is included in our Annual Report on Form 10-K for the year ended December 31, 2014 in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations”; our critical accounting policies have not changed during 2015.
Recent Accounting Pronouncements
See Note 2 to the Consolidated Financial Statements for the impact of new accounting standards. There are no accounting pronouncements that have been issued, but not yet adopted by us, that we believe will materially impact our consolidated financial statements; however we are still evaluating their impacts upon adoption.
Market risk
As filed, 4,154 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates and foreign currency exchange rates, specifically the pound sterling (“GBP”). We use derivative financial instruments in the normal course of business to mitigate interest rate and foreign currency risk. We do not use derivative financial instruments for speculative or trading purposes. Derivatives are recorded on the consolidated balance sheets at fair value (see Note 20 to the Consolidated Financial Statements).
To illustrate the effect of movements in the interest rate and foreign currency markets, we performed a market sensitivity analysis on our hedging instruments. We applied various basis point spreads to the underlying interest rate curves and foreign currency exchange rates of the derivative portfolio in order to determine the change in fair value. Assuming a one percentage point change in the underlying interest rate curve and foreign currency exchange rates, the estimated change in fair value of each of the underlying derivative instruments would not exceed $8 million (see Note 20 to the Consolidated Financial Statements).
Interest Rate Risk. At March 31, 2015, we are exposed to market risks related to fluctuations in interest rates primarily on variable rate debt, which has been predominately hedged through interest rate swap contracts.
Interest rate fluctuations will generally not affect our future earnings or cash flows on our fixed rate debt and assets until their maturity or earlier prepayment and refinancing. If interest rates have risen at the time we seek to refinance our fixed rate debt, whether at maturity or otherwise, our future earnings and cash flows could adversely be affected by additional borrowing costs. Conversely, lower interest rates at the time of refinancing may reduce our overall borrowing costs. However, interest rate changes will affect the fair value of our fixed rate instruments. Conversely, changes in interest rates on variable rate debt and investments would change our future earnings and cash flows, but not significantly affect the fair value of those instruments. Assuming a one percentage point increase in the interest rate related to the variable-rate debt and variable-rate investments, and assuming no other changes in the outstanding balance as of March 31, 2015, net interest expense would increase by approximately $3 million, or less than $0.01 per common share on a diluted basis.
Foreign Currency Risk. At March 31, 2015, our exposure to foreign currencies primarily relates to U.K. investments in leased real estate, senior unsecured notes and related GBP denominated cash flows. Our foreign currency exposure is partially mitigated through the use of GBP denominated borrowings and foreign currency swap contracts. Based solely on our operating results for the three months ended March 31, 2015, including the impact of existing hedging arrangements, if the value of the GBP relative to the U.S. dollar were to increase or decrease by 10% compared to the average exchange rate during the quarter ended March 31, 2015, our cash flows would have decreased or increased, as applicable, by less than $1 million.
Market Risk. We have investments in marketable debt securities classified as held-to-maturity because we have the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are recorded at amortized cost and adjusted for the amortization of premiums and discounts through maturity. We consider a variety of factors in evaluating an other-than-temporary decline in value, such as: the length of time and the extent to which the market value has been less than our current adjusted carrying value; the issuer’s financial condition, capital strength and near-term prospects; any recent events specific to that issuer and economic conditions of its industry; and our investment horizon in relationship to an anticipated near-term recovery in the market value, if any. At March 31, 2015, the fair value and carrying value of marketable debt securities were $230 million and $221 million, respectively.
Controls and procedures
As filed, 2,045 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures. We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934), management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
As required by Rules 13a-15(b) and 15d-15(b) of the Securities Exchange Act of 1934, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2015. Based upon that evaluation, our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer) concluded that our disclosure controls and procedures were effective at the reasonable assurance level.
Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 4,923 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
In addition to the information set forth in this Form 10-Q, you should carefully consider the risk factors discussed in Part I, Item 1A of our most recent Annual Report on Form 10-K, which could materially affect our business, financial condition, or future results. The following updates the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2014:
Our ownership interest in, and lease with, our largest tenant, HCRMC, accounts for a significant portion of our assets and revenues. Adverse litigation, regulatory or operational developments in HCRMC’s business or financial condition could have a material adverse effect on us.
HCRMC is a provider of a range of healthcare services, primarily in post-acute care, skilled nursing care and assisted living, and our largest tenant representing 29% and 25% of our gross assets and revenues, respectively, as of and for the quarter ended March 31, 2015. We also own a 9.4% equity interest in HCRMC, which we acquired together with our April 2011 $6 billion acquisition of substantially all the real estate assets of HCRMC. In December 2014, we recorded an impairment charge of $36 million for our equity ownership interest in HCRMC, primarily resulting from our review of their 2015 preliminary base financial forecast and other financial information provided by HCRMC that reflected a continued shift in patient payor sources from Medicare to Medicare Advantage, which negatively impacts reimbursement rates and length of stay for HCRMC’s skilled nursing segment. In March 2015, we also recorded a net impairment charge of $478 million relating to our investments in direct financing leases (“DFLs”) with HCRMC, which reduced the carrying value of the HCRMC DFL investments from $6.6 billion to $6.1 billion, based on the present value of the future lease payments under the amendment to our master lease with HCRMC that became effective April 1, 2015.
On April 20, 2015 the U.S. Department of Justice (“DOJ”) unsealed a previously filed complaint in the United States District Court for the Eastern District of Virginia against HCRMC and certain of its affiliates in three consolidated cases following a civil investigation arising out of three lawsuits filed by former employees of HCRMC under the qui tam provisions of the federal False Claims Act. The DOJ’s complaint in intervention is captioned United States of America, ex rel. Ribik, Carson, and Slough v. HCR ManorCare, Inc., ManorCare Inc., HCR ManorCare Services, LLC and Heartland Employment Services, LLC (Civil Action Numbers: 1:09cv13; 1:11cv1054; 1:14cv1228 (CMH/TCB)). The complaint alleges that HCRMC submitted claims to Medicare for therapy services that were not covered by the skilled nursing facility benefit, were not medically reasonable and necessary, and were not skilled in nature, and therefore not entitled to Medicare reimbursement.
HCRMC has advised HCP that it believes the claims are unjust and it intends to vigorously defend the civil action. Since the case is at a preliminary stage, the ultimate outcome is uncertain. However, this litigation could, among other things, (1) require substantial time and costs of HCRMC to defend; (2) involve a substantial judgment against HCRMC; (3) result in a settlement requiring a substantial payment by HCRMC; (4) result in HCRMC being subject to oversight of the Department of Health and Human Services, Office of Inspector General (“OIG”) under a corporate integrity agreement and/or OIG determining that HCRMC and/or certain of its employees are excluded from the right to seek reimbursements from Medicare or Medicaid; or (5) result in additional investigations or follow-on lawsuits by state Medicare or Medicaid authorities, state attorneys general, private insurers, or other public or private plaintiffs.
Consequences such as those described above relating to the DOJ complaint, continued deterioration in HCRMC’s operating performance or other adverse developments in its business, operating and regulatory affairs, or financial condition could reduce the revenues we earn under our master lease with HCRMC and/or further impair the value of our master lease with HCRMC, either of which could have a material adverse effect on us.
See additional information regarding the aforementioned impairment charge, 9.4% equity interest in HCRMC and Master Lease with HCRMC in: (i) Item 7 “Results of Operations” (post-acute/skilled nursing segment 2014/2013 comparison) of our Annual Report on Form 10-K for the year ended December 31, 2014 and Note 17 (Impairments) to the Consolidated Financial Statements included therein; and (ii) Note 6 (Net Investment in Direct Financing Leases), Note 8 (Investments in and Advances to Unconsolidated Joint Ventures) and Note 18 (Concentration of Credit Risk) to the Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-01-01 to 2015-03-31 | $610.8m | us-gaap:Revenues |
| Interest expense | 3 months2015-01-01 to 2015-03-31 | $116.8m | us-gaap:InterestExpense |
| Income tax | 3 months2015-01-01 to 2015-03-31 | −$77.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2015-01-01 to 2015-03-31 | −$240.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2015-01-01 to 2015-03-31 | −$0.52 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2015-01-01 to 2015-03-31 | −$0.52 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2015-01-01 to 2015-03-31 | 460,880,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2015-01-01 to 2015-03-31 | $230.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2015-01-01 to 2015-03-31 | $64.8m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 3 months2015-01-01 to 2015-03-31 | $260.7m | us-gaap:PaymentsOfDividends |
| Share repurchases | 3 months2015-01-01 to 2015-03-31 | $6.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2015-03-31 | $137.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2015-03-31 | $21.02bn | us-gaap:Assets |
| Total liabilities | At period end2015-03-31 | $10.47bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2015-03-31 | $10.29bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001558370-15-000716. Last ingested by Listed: Nov 14, 2026, 21:09 ET. Listed shows no prices and gives no investment advice.